Sodium Bicarbonate Uses and Dosages for Treating Acidosis
Sodium bicarbonate is primarily indicated for treating severe metabolic acidosis (pH < 7.1), hyperkalemia, and tricyclic antidepressant overdose, with specific dosing of 1-2 mEq/kg IV administered slowly for adults. 1, 2
Primary Indications for Sodium Bicarbonate
- FDA-approved for treating metabolic acidosis in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock, severe dehydration, extracorporeal circulation of blood, cardiac arrest, and severe primary lactic acidosis 1
- Strongly recommended (Class 1, Level B-NR) for treating life-threatening cardiotoxicity from tricyclic and tetracyclic antidepressant poisoning 3
- Reasonable (Class 2a, Level C-LD) for treating life-threatening cardiotoxicity caused by other sodium channel blockers 3
- Indicated for drug intoxications including barbiturates, salicylates, and methyl alcohol poisoning 1
- Used in hemolytic reactions requiring alkalinization of urine to reduce nephrotoxicity 1
- Indicated in severe diarrhea with significant bicarbonate loss 1
Dosing Guidelines
For Metabolic Acidosis:
- Standard initial dose: 1-2 mEq/kg IV administered slowly 2, 4
- For severe acidosis (pH < 7.1 and base excess < -10): 50 mmol (50 ml of 8.4% solution) 3
- Further administration depends on clinical situation and repeat arterial blood gas analysis 3
For Sodium Channel Blocker Toxicity:
- Adults: Hypertonic solution (1000 mEq/L) given as IV bolus 3
- Children: Hypertonic solution (500 mEq/L) given as IV bolus 3
- Titrate to resolution of hypotension and QRS prolongation 3
- May continue with infusion of 150 mEq NaHCO₃/L solution to maintain alkalosis after initial bolus 2
pH-Based Recommendations:
- pH < 6.9: Bicarbonate therapy may be beneficial 4
- pH 6.9-7.0: 1-2 mEq/kg over 1 hour 4
- pH > 7.0: Generally not necessary 4
Monitoring and Administration Guidelines
- Ensure effective ventilation is established before administering bicarbonate (ventilation needed to eliminate excess CO₂ produced) 2, 4
- Monitor serum bicarbonate every 2-4 hours during active infusion therapy 4
- Follow venous pH and anion gap to monitor resolution of acidosis 4
- Continue infusion until serum bicarbonate reaches ≥22 mmol/L or pH rises above 7.0 4
- Avoid extremes of hypernatremia (serum sodium not to exceed 150-155 mEq/L) 3
- Avoid extremes of alkalemia (serum pH not to exceed 7.50-7.55) 3
- Monitor and treat hypokalemia during alkalemia therapy 3
- Do not mix sodium bicarbonate with vasoactive amines or calcium 2
Cautions and Contraindications
- Not recommended for routine use in cardiac arrest 2
- Not recommended for hypoperfusion-induced lactic acidemia with pH ≥ 7.15 in sepsis 2, 5, 6
- Not supported for routine use in diabetic ketoacidosis, may cause harm in pediatric patients 5
- Potential adverse effects include:
- Extracellular alkalosis (shifting oxyhemoglobin curve and inhibiting oxygen release) 2
- Hypernatremia and hyperosmolarity 2
- Excess CO₂ production causing paradoxical intracellular acidosis 2, 7
- Inactivation of simultaneously administered catecholamines 2
- Hypokalemia and hypocalcemia 8, 7
- Sodium and fluid overload 5
Alternative Alkalizing Agents
- THAM (tromethamine) may be preferred in patients with:
- However, sodium bicarbonate has a longer-lasting alkalizing effect than THAM 8
- THAM is not recommended for patients with hyperkalemia (bicarbonate decreases serum potassium, THAM does not) 8